Adenylyl cyclase is a family of enzymes that catalyze the formation of adenosine 3':5'-monophosphate (cAMP) from ATP. It also belongs to a superfamily of membrane-bound transporter and channel proteins. Mammalian forms of the enzyme are stimulated or inhibited by hormones via G-protein- linked cell-surface receptors. Adenylyl cyclases are also inhibited via a cytoplasmic domain (""""""""P""""""""-site) by adenine nucleoside 3'-phosphates that derive from nucleic acid metabolism. Thr proposed investigations focus on this inhibition of adenylyl cyclases via the """"""""P""""""""-site. The several isozymes of adenylyl cyclase, whether extracted from various tissues or expressed in Sf9 cells, exhibit different sensitivities to """"""""P""""""""-site- mediated inhibition that may reflect differing physiological roles for this inhibition in tissues expressing the respective forms of the enzyme. The general focus of the proposal is to utilize biochemical probes to define structural characteristics of the inhibitory domain and to utilize selected probes to define its locus within selected expressed wild type and mutated isozymes. A very important corollary to this approach is to identify and quantify naturally occurring """"""""P""""""""=site inhibitors and to identify the pathways of their synthesis and degradation. These approaches build on our recent discovery that 3'-polyphosphorylated adenine nucleotides are a very potent, previously undescribed class of inhibitor of adenylyl cyclases. Characteristics of """"""""P""""""""-site-mediated inhibition will be determined for the different adenylyl cyclases. Characteristics of """"""""P""""""""-site-mediated inhibition will be determined for the different adenylyl cyclase isozymes, with emphasis on ligand specificity and the role of post-translational modification through phosphorylation-dephosphorylation mechanisms, specifically involving protein kinases C and A. Recently synthesized ligands will be tested further and additional site-selective ligands will be made. Emphasis will be on selective and high-affinity probes that can be used for covalent attachment tot he """"""""P""""""""-site, that can be labeled with radioactive tracers and/or with fluorescent indicators, that are metabolically and chemically stable, and probes that can be used either directly or as prodrugs to inactivate adenylyl cyclase in intact cells. Radioactive covalent affinity probes will be used to tag the """"""""P""""""""-site. Initial probes will be based on 3'-polyphosphorylated adenine nucleosides. Labeled peptides will be isolated and sequenced an these will be compared with those of the adenylyl cyclases and other proteins. Cellular levels of """"""""P""""""""-site ligands will be determined. High affinity ligands will be used for the identification and quantification of naturally occurring """"""""P""""""""-site ligands and of possibly other proteins to which this class of nucleotide binds. The proposed studies will provide a unique handle on adenylyl cyclase. Characteristics for this new class of modulator of adenylyl cyclases will be defined, and the regulatory links between this family of enzymes and nucleic acid metabolism will be strengthened.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK038828-11
Application #
2684169
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Margolis, Ronald N
Project Start
1986-09-01
Project End
2000-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
11
Fiscal Year
1998
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Physiology
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Laux, Wolfgang H G; Pande, Praveen; Shoshani, Ilana et al. (2004) Pro-nucleotide inhibitors of adenylyl cyclases in intact cells. J Biol Chem 279:13317-32
Shoshani, I; Taussig, R; Iyengar, R et al. (2000) Synthesis and use of 3'-(azidoiodosalicyl) derivatives of 2', 5'-dideoxyadenosine as photoaffinity ligands for adenylyl cyclase. Arch Biochem Biophys 376:221-8
Tesmer, J J; Dessauer, C W; Sunahara, R K et al. (2000) Molecular basis for P-site inhibition of adenylyl cyclase. Biochemistry 39:14464-71
Shoshani, I; Bianchi, G; Desaubry, L et al. (2000) Lys-Ala mutations of type I adenylyl cyclase result in altered susceptibility to inhibition by adenine nucleoside 3'-polyphosphates. Arch Biochem Biophys 374:389-94
Shoshani, I; Laux, W H; Perigaud, C et al. (1999) Inhibition of adenylyl cyclase by acyclic nucleoside phosphonate antiviral agents. J Biol Chem 274:34742-4
Doronin, S; Murray, L; Dessauer, C W et al. (1999) Covalent labeling of adenylyl cyclase cytosolic domains with gamma-methylimidazole-2',5'-dideoxy-[gamma-(32)P]3'-ATP and the mechanism for P-site-mediated inhibition. J Biol Chem 274:34745-50
Szczepanik, M B; Desaubry, L; Johnson, R A (1999) Synthesis of nucleoside 3'-thiophosphates in one step procedure. Nucleosides Nucleotides 18:951-3
Johnson, R A; Shoshani, I; Dessauer, C et al. (1999) Enzymatic preparation of 32P-labeled beta-L-2',3',-dd-5'ATP and its use as a high-affinity, conformation-specific ligand for labeling adenylyl cyclases. Nucleosides Nucleotides 18:839-42
Tesmer, J J; Sunahara, R K; Johnson, R A et al. (1999) Two-metal-Ion catalysis in adenylyl cyclase. Science 285:756-60
Ibrahimi, A; Abumrad, N; Maghareie, H et al. (1999) Adenylyl cyclase P-site ligands accelerate differentiation in Ob1771 preadipocytes. Am J Physiol 276:C487-96

Showing the most recent 10 out of 28 publications